Janus Henderson Institutional UK Index Opportunities Trust A Inc
|AstraZeneca PLC||5.79 %|
|HSBC Holdings PLC||4.44 %|
|GlaxoSmithKline PLC||4.38 %|
|British American Tobacco PLC||3.78 %|
|Diageo PLC||3.38 %|
|BP PLC||3.36 %|
|Royal Dutch Shell PLC B||2.57 %|
|Royal Dutch Shell PLC Class A||2.57 %|
|Unilever PLC||2.34 %|
|Reckitt Benckiser Group PLC||2.21 %|
|United Kingdom||91.38 %|
|Consumer Defensive||17.46 %|
|Financial Services||17.29 %|
|Basic materials||9.24 %|
|Consumer Cyclical||7.88 %|
|Communication Services||7.12 %|
David Elms, Director of Market Neutral & Enhanced Equities, joined Henderson in December 2002. Prior to joining Henderson, David was a founding partner of Portfolio Partners, a boutique asset manager based in Australia, where he was responsible for enhanced index equities, derivatives and high yield fixed income.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.